Aryl aminopyridine PDE10 inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 8, 2013
Grant Date -
Aug 2, 2012
app pub date -
Oct 26, 2010
filing date -
Oct 30, 2009
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention is directed to aryl aminopyridine compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully